Although there is a limitation in a clinical study with one pathologist using a limited number of cases, our study successfully showed a flow cytometry method with the newly developed pretreatment process of FFPE specimens could potentially be used to standardize Ki67 assessments in breast cancer. The gene discussed is MKI67; the disease is breast cancer.